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The interaction of ascorbate with different heme iron redox states of myoglobin (ferrylmyoglobin, Fe’“=O; metmyoglobin, Fe”‘; and oxymyoglobin, 
Fe”03 was examined by e.s.r. and absorption spectroscopy. The reaction of ascorbate with ferryl- or met-myoglobin resulted in ascorbyl radical 
production. The interaction of ascorbate with oxymyoglobin proceeded with formation of ascorbyl radical, hydrogen peroxide, and an overall 
oxidation of oxymyoglobin to metmyoglobin. The latter reaction proceeded via an oxoferryl complex intermediate - corresponding to ferrylmyo- 
globin and identified by treatment of the reaction mixture with Na,S. These observations are consistent with a concerted electron transfer 
mechanism, whereby the two electrons required for the reduction of oxygen to hydrogen peroxide are donated by ascorbic acid and the heme iron. 
The antioxidant and prooxidant aspects of these redox transitions are discussed in terms of their kinetic properties. 
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1. INTRODUCTION 
The oxidant generated during the reaction of 
metmyoglobin (or methemoglobin) with H,O, is known 
as ferrylmyoglobin (or ferrylhemoglobin), a species 
which contains hypervalent heme iron in the form of an 
oxoferryl complex as well as an amino acid radical [ 1,2]. 
The heterolytic cleavage of the 0-O bond of the perox- 
ide by myoglobin leading to ferrylmyoglobin formation 
is conventionally written as in reaction 1 (where 
FeIV=O, stands for the oxoferryl moiety in ferrylmyog- 
lobin; HX- for an amino acid; Fe”’ for metmyoglobin). 
HX-Fe’” + H,O, + ‘X-Fen’=0 + HZ0 (I) 
Ferrylmyoglobin has assumed high significance 
within the context of coronary heart diseases [3-51, a 
notion partly based on the broad chemical reactivity 
and long-life time of the oxoferryl complex and, hence, 
its potential implication in cellular oxidative damage. 
As a corollary, several antioxidants or electron donors 
have been evaluated in terms of their ability to reduce 
*Corresponding author. 2.1. Chemicals and biochemrcals 
Abbreviations: AH,, ascorbic acid; AH-, ascorbate monoanion; A’-, 
ascorbyl radical; Fe’“=O, oxo-ferry1 complex in ferryhnyoglobin; 
HX-Fe’“=O, ferrylmyoglobin; HX-Fe”‘, metmyoglobin; HX-Fe*‘O,, 
oxymyoglobin. 
Horse heart myoglobin was purchased from Fluka Chemical Co. 
(Ronkonkoma, NY, USA) and it was dialyzed against 1 mM EDTA/ 
0.1 mM potassium phosphate buffer, pH 7.4, for 2 h prior to use. 
Ascorbic acid and H,02 were from Sigma Chemical Co. (St. Louis, 
MO, USA); beef liver catalase was from Pharmacia (Uppsala, Swe- 
the hypervalent heme iron in ferrylmyoglobin to met- 
or oxymyoglobin [6--Q. Ascorbic acid reduces efficiently 
ferrylmyoglobin [8-lo] and also metmyoglobin [lo] - 
albeit at slower rates. Although absorption spectral 
evidence was provided for the ferrylmyoglobin 
+ metmyoglobin redox transition [S-lo], the genera- 
tion of ascorbyl radical (A’-) by this process remained 
hypothetical. The formation of this weak oxidizing rad- 
ical is expected to ensue from the electron-transfer 
depicted in reaction (2). 
I-IX-Ferv=O + AH- + H’ + HX-Fe”’ + A’- + Hz0 (2) 
In this study, we provide evidence that the formation 
of ascorbyl radical is a feature inherent not only in the 
reaction of ascorbate with the hypervalent heme iron, 
but also in the reaction with the ferric (metmyoglobin) 
and ferrous (oxymyoglobin) forms of the hemoprotein. 
The interaction of ascorbate with the latter species ap- 
pears to bear a pro-oxidant character, inasmuch as it is 
associated with H,O, and ferrylmyoglobin formation. 
2. MATERIALS AND METHODS 
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3. RESULTS 
3. 1. Ascorbic acid-mediated reduction offerryl- and met- 
myoglobin 
The interaction of ascorbate with ferryl- and met- 
den) and superoxide dismutase from Boehringer (Mannheim, Ger- 
many). Oxymyoglobin was obtained by reduction of metmyoglobin 
with dithionite in an oxygen-free solution as previously described [l 11. 
Ferrylmyoglobin was formed upon incubation of equimolar amounts 
of metmyoglobm and H,O,. 
2.2. Absorption spectroscopy 
Concentrations of oxymyoglobin (bus,, = 14.4 mM-’ cm-‘), 
metmyoglobin (Ebb,, =2.1 mM-’ cm-‘), and ferrylmyoglobin (meas- 
ured at 550 and 630 nm according to the following formula: [fer- 
rylmyoglobin] @M) = 249 A,,, nm - 367 A630 .,) were determined 
spectrophotometrically. Derivatization of ferrylmyoglobin to 
sulfmyoglobin was accomplished upon addition of Na,S; sulfmyo- 
globin displayed a characteristic absorption at 621 nm (E = 24 
M-’ . cm-‘) [12]. 
2.3. Electron spin resonance (e.s.r.) spectroscopy 
e.s.r. spectra were recorded at 9.81 GHz on a Brucker ECS 106 
spectrophotometer. Measurements were carried out with 100 kHz 
field modulation at room temperature. The instrument settings were: 
receiver gain, 2 x 106; microwave power, 10 mW, microwave fre- 
quency, 9.81 GHz; modulation amplitude, 1.527 G; time constant, 1.3 
s; scan time, 5.6 min. 
2.4. Polarographic measurements 
H,O, formation was measured as 0, evolved m a reaction mixture 
containing different amounts of oxymyoglobin (2&80 PM) and a 
5-lo-fold excess of ascorbic acid in helium-purged 0.1 M potassium 
phosphate buffer, pH 5.5.0, evolution was measured with an oxygen 
Clark-type electron in the presence of catalase (500 U ml-‘). H,O, 
formed was quantified taking into account that [H,O,] = 0.5 [O?]. 
myoglobin at pH 7.4 (Fig. 1, left panel) resulted in an 
e.s.r. signal characterized by a doublet (1:l) with a hy- 
perfine coupling constant of aH4 1.8 G (g = 2.00518) and 
consistent with the spectrum ascribed to ascorbyl radi- 
cal [13]. The ascorbyl radical e.s.r. signal intensity re- 
sulting from the interaction of ascorbate with fer- 
rylmyoglobin was 1.45-fold higher than that originating 
from the interaction of the antioxidant with metmyo- 
globin. This higher steady-state concentration of as- 
corbyl radical was expected, for ascorbate reacts much 
faster with ferrylmyoglobin (1.6 + 0.4 x lo6 M-l * s-l) 
than it does with metmyoglobin (3.3 x lo2 M-’ * SC’). 
(The experimental rate constant for the former reaction 
was similar to that reported for the reaction of fer- 
rylmyoglobin with the water-soluble analog of vitamin 
E, Trolox [14].) In the absence of hemoprotein, a low 
intensity ascorbyl radical signal was observed (Fig. 1 C) 
which was accounted for by the autoxidation of ascor- 
bate at this pH. The pK, value for ascorbic acid is 4.25 
and at pH 7.4 the concentration of the mono-anionic 
form (AH-) is higher than that of the protonated form 
(AH,). Ascorbic acid dissociation (AH, e AH-) is a 
requisite condition for its participation in electron- 
transfer reactions. Indeed, at pH 5.5 ([AH,] > [AH-]), 
the ascorbyl radical signal originating from ascorbic 
acid autoxidation was abolished (Fig. IF), whereas 
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Fig. 1. Ascorbyl radical formation during the reaction of ascorbate 
with ferryl- or metmyoglobin. Left panel: the reaction mixture con- 
sisted of 1 mM ascorbic acid in 0.1 M potassium phosphate buffer, 
pH 7.4, supplemented with either (A) 0.2 mM ferrylmyoglobin or (B) 
0.2 mM metmyoglobin; (C) no additions. Right panel: the same as 
above but at pH 5.5; (D) plus ferrylmyoglobin; (E) plus metmyo- 
globin; (F) no additions. Instrument settings as described in section 
2. Instrument scale: left panel, 19; right panel, 17. 
those arising from interaction of ascorbic acid with ei- 
ther ferryl- or metmyoglobin still persisted, although 
they were 5- and 3-fold lower, respectively, than those 
observed at pH 7.4 (Fig. 1, right panel). Overall, the 
results obtained at pH 5.5 and 7.4 indicate that the 
interaction of ascorbic acid with ferryl- or metmyo- 
globin entails a one-electron transfer process yielding 
ascorbyl radicals as illustrated for the case of fer- 
rylmyoglobin in reaction (2). 
3.2. Interaction of ascorbic acid with oxymyoglobin 
The interaction of ascorbate with oxymyoglobin had 
the following characteristic features: 
First, at pH 7.4 it resulted in the formation of an 
ascorbyl radical e.s.r. signal, the intensity of which was 
similar to that observed upon reaction of ascorbate with 
ferrylmyoglobin and 1.4-fold higher than that with 
metmyoglobin (Fig. 2A). Superoxide dismutase and cat- 
alase decreased slightly (15%) the e.s.r. signal intensity 
(Fig. 2B,E). At pH 5.5, the ascorbyl radical signal inten- 
sity was 5.9-fold lower than at pH 7.4 (Fig. 2D), super- 
oxide dismutase did not affect the signal intensity, and 
catalase decreased it as at pH 7.4 (Fig. 2C,F). The lack 
of effect of superoxide dismutase suggests that O;- is not 
involved in ascorbyl radical formation at pH 5.5. The 
slight inhibitory effect exerted by catalase at this pH 
value is discussed below. 
Second, the interaction between ascorbic acid and 
oxymyoglobin was associated with H202 formation evi- 
denced as a catalase-mediated 0, evolution. Horse- 
radish peroxidase-based methods for H,O, measure- 
ments could not be used in this experimental model 
because ascorbic acid, at the concentration used, effec- 
tively reduced compound II, thus preventing its reaction 
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pH 7.4 pH 5.5 
Fig. 2. Ascorbyl radical formation during the reaction of ascorbate 
with oxymyoglobin. Lefr panel: the reaction mixture consisted of 1 
mM ascorbic acid in 0.1 M potassium phosphate buffer, pH 7.4, 
supplemented with 0.2 mM oxymyoglobin. (A) No additions; (B) plus 
I PM superoxide dismutase; (C) plus 500 U . ml-’ catalase. Right 
punel: as above at pH 5.5. Instrument settings as described in section 
2. Instrument scale: left panel, 19; right panel, 17. 
with the fluorescent probe. H,O1 formation was evalu- 
ated at pH 5.5 in order to minimize the contribution of 
ascorbate autoxidation to H202 steady-state. The 
amount of H,O, formed was linearly related to oxy- 
myoglobin concentration (Fig. 3) and dependent on 
the [ascorbic acid]/[oxymyoglobin] ratio: at a ratio of 5, 
the total yield of H202 was about 30% of the hemopro- 
tein present, whereas at [ascorbic acid]/[oxymyo- 
globin] = 10, the amount of H202 formed was equimo- 
lar to the hemoprotein concentration (Fig. 3, insert). 
Third, the reaction of ascorbate with oxymyoglobin 
was accompanied by absorption spectral changes - con- 
sisting of a small decrease in absorbance at 580 and 545 
nm and a slight increase at 630 nm - ascribed to the 
oxymyoglobin + metmyoglobin (Fe”0, + Fe”‘) tran- 
sition (Fig. 4A). Treatment of the reaction mixture with 
Na,S revealed the presence of a strong absorption at 
621 nm (Fig. 4B), which is indicative of sulfmyoglobin. 
The occurrence of the oxoferryl complex, as in fer- 
rylmyoglobin, is a requisite condition to observe 
sulfmyoglobin formation, which occurs upon sulfur nu- 
cleophilic attack onto a /?-carbon atom of a pyrrole [ 121. 
Hence, the results shown in Fig. 4B reveal the presence 
of an oxoferryl intermediate during the interaction of 
oxymyoglobin with ascorbate. These findings also ex- 
plain the slight inhibitory effect of catalase on e.s.r. 
signal intensity corresponding to ascorbyl radical, indi- 
cating the contribution of ferrylmyoglobin - formed 
upon interaction of metmyoglobin with H,O, - to as- 
corbyl radical formation. 
The experimental evidence presented here, entailing 
the formation of ascorbyl radical and H,O, as well as 
that of an oxoferryl complex intermediate, is consistent 
with a mechanism encompassed by the following se- 
quence (a) A concerted electron transfer to 0, in oxy- 
myoglobin yielding ascorbyl radical, metmyoglobin, 
and H,Oz. The formation of ascorbyl radical and 
metmyoglobin (implying one-electron oxidations), indi- 
cates that the two electrons required for the reduction 
of O2 to H,Oz are contributed by ascorbate and the 
heme iron. This view further suggests that oxymyo- 
globin occurs partly as superoxoferrimyoglobin (HX- 
Fe”‘O;-) [15] in order to facilitate the initial oxi- 
dation of ascorbate (reaction 3). (b) Rapid oxida- 
tion of metmyoglobin by H202 yielding ferrylmyoglobin 
(reaction (1) 
[HX-Fe”0, w HX-Fe”‘O;-] + AH- + H’ + 
HX-Fe”’ + H202 + A’- (3) 
above). (c) Reduction of the oxoferryl derivative to 
metmyoglobin as indicated in reaction (2) 
(k2 = 1.6 + 0.4 x lo6 M-’ * SC’) and the experimental ob- 
servations in Fig. 1 and previous reports [8-lo]. Steps 
(b) and (c) above explain the lack of direct absorption 
spectral evidence for ferrylmyoglobin (i.e., only the ox- 
ymyoglobin + metmyoglobin transition in Fig. 4A is 
observed) and the necessity to displace this species from 
the equilibrium upon its derivatization to sulfmyoglobin 
(Fig. 4B). 
4. DISCUSSION 
In this study, we provided evidence that ascorbyl rad- 
ical is indeed generated during the reduction of fer- 
rylmyoglobin by ascorbate as previously suggested by 
monitoring the ferrylmyoglobin + metmyoglobin con- 
version. The antioxidant feature inherent in this reac- 
tion is suggested by the removal of ferrylmyoglobin (a 
strong oxidant with a reduction potential of about + 1.4 
V) [16] and transfer of the radical character to ascor- 
bate; the ascorbyl radical is a weak oxidant (+0.28 V) 
,C 
[Oxymyo$bm, (MM) 
80 
Fig. 3. H,O, formation during the reaction of ascorbate and oxymyo- 
globin. Assay conditions: different amounts of oxymyoglobin (l&80 
PM) in helium-purged 0.1 M potassium phosphate buffer, pH 5.5, 
were supplemented with ascorbic acid (to reach a [ascorbic acidy 
[myoglobin] ratio of 5 or 10. Insert: [H,O,~~,,~[oxymyoglobin],,, 
ratio vs. [ascorbic acidy[oxymyoglobin]. Abbreviation: oxyhlb, 
oxymyoglobin. 
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Fig. 4. Visible absorption spectral changes during the reaction of 
oxymyoglobin with ascorbate. (A) Assay conditions: 50pM oxymyo- 
globin in 0.1 mM potassium phosphate buffer, pH 7.4, was supple- 
mented with 2 mM ascorbic acid to initiate the reaction. (---) 
oxymyoglobin; (-) oxymyoglobin plus ascorbic acid. Scans were 
taken at 1 min intervals. (B) Assay conditions: oxymyoglobin was 
incubated with ascorbate for 10 min (as in (A)) (---). After this period, 
1 mM Na,S to derivatize ferrylmyoglobin to sulfmyoglobin (-_). The 
upward and downward arrows indicate increase and decrease in ab- 
sorbance, respectively. Scan intervals: 1 min. 
[17], which can readily decay by disproportionation to 
nonradical products [ 181. This, along with the proposed 
role for ferrylmyoglobin in coronary heart diseases [3- 
5] and the reported protective effect of ascorbate in 
induced ischemic arrest associated with cardiopulmon- 
ary bypass [16], suggests a potential antioxidant func- 
tion for ascorbate against oxidative damage during cer- 
tain cardiomyopathies. 
The interaction of ascorbate with oxymyoglobin, en- 
compassing the sequence of reactions (3)-(l)-(2) above, 
is reminiscent of the reaction of oxyhemoglobin with 
acetylphenylhydrazine [20] and with NO; [21]; in the 
former case, a methemoglobin-H,O, intermediate com- 
plex was proposed, although it was not identified as the 
oxoferryl complex of ferrylhemoglobin, whereas in the 
latter case, ferrylmyoglobin was shown to be an inter- 
mediate. In this study, the identification of potent oxi- 
dant, such as ferrylmyoglobin, ensuing from the interac- 
tion of ascorbate with oxymyoglobin, was accomplished 
by its derivatization to sulfmyoglobin (Fig. 4B). The 
occurrence of this oxoferryl complex intermediate sug- 
gests the prooxidant character of this redox transition. 
[18] Bielski, B.H.J. (1982) in: Ascorbic Acid: Chemistry, Metabohsm, 
and Uses (Seib, P.A. and Tolbert, B.M., Eds.) pp. 81-100, Amer- 
ican Chemical Society, Washington. 
[19] Eddy, L., Hurvitz, R. and Hochstein, P. (1990) J. Appl. Cardiol. 
5,409414. 
[20] French, J.K., Winterbourn, C.C. and Carrel], R.W. (1978) Bio- 
them. J. 173, 19-26. 
The interactions of ascorbic acid with different heme [21] Arduini, A., Mancinelli, G., Radatti, G.L., Hochstein, P. and 
iron redox states of myoglobin reveal antioxidant and Cadenas, E. (1992) Arch. Biochem. Biophys. 294, 398402. 
prooxidant features: the former is substantiated by the 
reduction of ferrylmyoglobin by ascorbate (reaction 
(4)~) whereas the latter by the oxidation of oxymyo- 
globin by ascorbate, in the course of which a ferrylmyo- 
globin intermediate is formed (reaction (4)b). Evalua- 
tion of the significance of the latter aspect requires 
consideration of absolute rate constants and steady- 
state concentrations of reactive intermediates. Although 
it could be argued that the oxoferryl intermediate is 
readily reduced back to metmyoglobin by ascorbate (as 
in reaction (2)) thus preventing its oxidative interaction 
with bioconstituents, it is also possible that in appropri- 
ate cellular settings other electron donors would com- 
pete efficiently with ascorbate. The radical species 
formed during this interaction may not be a weak oxi- 
dant as the ascorbyl radical and it could propagate 
oxidative reactions. 
Acknowledgements: Supported in part by Grant No. ES05423 from 
NIEHS. 
REFERENCES 
Ul 
PI 
[31 
[41 
[51 
161 
[71 
PI 
[91 
1101 
[ill 
WI 
[I31 
1141 
1151 
1161 
[I71 
George, P. and Irvine, D.H. (1952) Biochem. J. 52, 51 l-517. 
King, N.K., Looney, F.D. and Winfield, M.E. (1967) Biochim. 
Biophys. Acta 88, 233-235. 
Galaris, D., Edy, L., Arduini, A., Cadenas, E. and Hochstein, P. 
(1989) Biochem. Biophys. Res. Commun. 160, 1162-l 168. 
Turner, J.J.O., Rice-Evans, C., Davies, M.J. and Newman, E.S. 
(1990) B&hem. Sot. Trans. 18, 10561059. 
Turner, J.J.O., Rice-Evans, C.A., Davies, M.J. and Newman, 
E.S.R. (1991) Biochem. J. 277, 833-837. 
Romero, F.J., Ordofiez, I., Arduini, A. and Cadenas, E. (1992) 
J. Biol. Chem. 267, 1680-1688. 
Arduini, A., Mancinelli, G., Radatti, G.L., Hochstein, P. and 
Cadenas, E. (1992) Arch. Biochem. Biophys. 294, 398402. 
Rice-Evans, C., Okunade, G. and Khan, R. (1989) Free Radical 
Res. Comm. 7. 45-54. 
Kanner, J. and Harel, S. (1985) Lipids 20, 625628. 
Galaris. D., Cadenas, E. and Hochstein, P. (1989) Arch. Bio- 
them. Biophys. 273.497-504. 
Giuhvi, C. and Davies, K.J.A. (1990) J. Biol. Chem. 265, 19453- 
19460. 
Berzofsky, J.A., Peisach, J. and Blumberg, W.E. (1971) J. Biol. 
Chem. 246, 3361-3377. 
Laroff, G.P., Fessenden, R.W. and Schuler, R.H. (1972) J. Am. 
Chem. Sot. 94,9062-9073. 
Giulivi, C., Romero, F.J. and Cadenas, E. (1992) Arch. Biochem. 
Biophys. 299, 302-312. 
Collman, J.P.. Brauman, J.I., Halbert, T.R. and Suslick, K.S. 
(1976) Proc. Natl. Acad. Sci. USA 73, 3333-3337. 
Shiga, T. and Imaizumi, K. (1975) Arch. Biochem. Biophys. 167, 
469479. 
Koppenol, W.H. and Butler, J. (1985) Adv. Free Radical Biol. 
Med. 1, 91-131. 
